Gerard Aurigemma to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Gerard Aurigemma has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.478
-
Aurigemma GP, Keaney JF. Renin-angiotensin system inhibition for aortic stenosis "A II, Brut??". J Am Coll Cardiol. 2011 Aug 02; 58(6):577-80.
Score: 0.359
-
Rist A, Sevre K, Wachtell K, Devereux RB, Aurigemma GP, Smiseth OA, Kjeldsen SE, Julius S, Pitt B, Burnier M, Kreutz R, Oparil S, Mancia G, Zannad F. The current best drug treatment for hypertensive heart failure with preserved ejection fraction. Eur J Intern Med. 2024 Feb; 120:3-10.
Score: 0.052
-
Gaasch WH, Aurigemma GP. Inhibition of the renin-angiotensin system and the left ventricular adaptation to mitral regurgitation. J Am Coll Cardiol. 2002 Apr 17; 39(8):1380-3.
Score: 0.047
-
Seth PS, Aurigemma GP, Krasnow JM, Tighe DA, Untereker WJ, Meyer TE. A syndrome of transient left ventricular apical wall motion abnormality in the absence of coronary disease: a perspective from the United States. Cardiology. 2003; 100(2):61-6.
Score: 0.012
-
Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation. 1995 May 15; 91(10):2642-54.
Score: 0.007